CXCR2 and chronic myelogenous leukemia, BCR-ABL1 positive: An in vivo study demonstrated the upregulation of Cxcl1 on murine stromal cells (akin to human perivascular MSCs) in CML, with upregulation of LSC Cxcr2, the Cxcl1 receptor.